Nonparenchymal cells, inflammatory macrophages, and hepatotoxicity

Drug-Induced Liver Disease, Second Edition

Volumn , Issue , 2007, Pages 159-184

  Laskin, Debra L ^a   Gardner, Carol R ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012843739     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (370)

1. Bouwens L, Baekeland M, De Zanger R, et al. Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver. Hepatology 1986; 6(4):718-22.
2. Caperna TJ, Garvey JS. Antigen handling in aging. II. The role of Kupffer and endothelial cells in antigen processing in Fischer 344 rats. Mech Ageing Dev 1982; 20(3):205-21.
3. Terpstra V, van Berkel TJ. Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood 2000; 95(6):2157-63.
4. van Oosten M, van de Bilt E, van Berkel TJ, et al. New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect Immun 1998; 66(11):5107-12.
5. Sano A, Taylor ME, Leaning MS, et al. Uptake and processing of glycoproteins by isolated rat hepatic endothelial and Kupffer cells. J Hepatol 1990; 10(2):211-6.
6. Ahmad N, Gardner CR, Yurkow EJ, et al. Inhibition of macrophages with gadolinium chloride alters intercellular adhesion molecule-1 expression in the liver during acute endotoxemia in rats. Hepatology 1999; 29(3):728-36.
7. Pilaro AM, Laskin DL. Accumulation of activated mononuclear phagocytes in the liver following lipopolysaccharide treatment of rats. J Leukoc Biol 1986; 40(1):29-41.
8. Gardner CR, Wasserman AJ, Laskin DL. Differential sensitivity of tumor targets to liver macrophage- mediated cytotoxicity. Cancer Res 1987; 47(24 Pt. 1):6686-91.
9. Gardner CR, Wasserman AJ, Laskin DL. Liver macrophage mediated cytotoxicity involves phagocytosis of tumor targets. Hepatology 1991; 14(2):318-24.
10. Løvdal T, Andersen E, Brech A, et al. Fc receptor mediated endocytosis of small soluble immunoglobulin G immune complexes in Kupffer cells and endothelial cells from rat liver. J Cell Sci 2000; 113(Pt. 18):3255-66.
11. Shi J, Fujieda H, Kokubo Y, et al. Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology 1996; 24(5):1256-63.
12. Bykov I, Ylipaasto P, Eerola L, et al. Phagocytosis and LPS-stimulated production of cytokines and prostaglandin E2 is different in Kupffer cells isolated from the periportal or perivenous liver region. Scand J Gastroenterol 2003; 38(12):1256-61.
13. Naito M, Hasegawa G, Ebe Y, et al. Differentiation and function of Kupffer cells. Med Electron Microsc 2004; 37(1):16-28.
14. Parker GA, Picut CA. Liver immunobiology. Toxicol Pathol 2005; 33(1):52-62.
15. Helmy KY, Katschke KJ, Jr., Gorgani NN, et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006; 124(5):915-27.
16. Zuo G, Gong J, Liu C, et al. Synthesis of Toll-like receptor 4 in Kupffer cells and its role in alcoholinduced liver disease. Chin Med J (Engl) 2003; 116(2):297-300.
17. Gustot T, Lemmers A, Moreno C, et al. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 2006; 43(5):989-1000.
18. Yamashina S, Takei Y, Ikejima K, et al. Ethanol-induced sensitization to endotoxin in Kupffer cells is dependent upon oxidative stress. Alcohol Clin Exp Res 2005; 29(Suppl. 12):246S-50.
19. Mathison JC, Ulevitch RJ. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979; 123(5):2133-43.
20. Nolan J. Endotoxin, reticuloendothelial function and liver injury. Hepatology 1981; 1(5):458-65.
21. Lukkari TA, Jarvelainen HA, Oinonen T, et al. Short-term ethanol exposure increases the expression of Kupffer cell CD14 receptor and lipopolysaccharide binding protein in rat liver. Alcohol 1999; 34(3):311-9.
22. Su GL, Klein RD, Aminlari A, et al. Kupffer cell activation by lipopolysaccaride in rats: role for lipopolysacchaide binding protein and toll-like receptor 4. Hepatology 2000; 31(4):932-6.
23. Su GL, Gong KQ, Fan MH, et al. Lipopolysaccharide-binding protein modulates acetaminopheninduced liver injury in mice. Hepatology 2005; 41(1):187-95.
24. Shnyra A, Lindberg AA. Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro. Infect Immun 1995; 63(3):865-73.
25. McCloskey TW, Todaro JA, Laskin DL. Lipopolysaccharide treatment of rats alters antigen expression and oxidative metabolism in hepatic macrophages and endothelial cells. Hepatology 1992; 16(1):191-203.
26. Laskin DL, Pilaro AM. Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. Toxicol Appl Pharmacol 1986; 86(2):204-15.
27. Tanner A, Keyhani A, Reiner R, et al. Proteolytic enzymes released by liver macrophages may promote injury in a rat model of hepatic damage. Gastroenterology 1981; 80(4):647-54.
28. Liu P, McGuire GM, Fisher MA, et al. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock 1995; 3(1):56-62.
29. Laskin DL, Heck DE, Gardner CR, et al. Distinct patterns of nitric oxide production in hepatic macrophages and endothelial cells following acute exposure of rats to endotoxin. J Leukoc Biol 1994; 56(6):751-8.
30. Feder LS, Laskin DL. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF and IL-1β following acute endotoxemia. J Leukoc Biol 1994; 55(4):507-13.
31. Laskin DL. Xenobiotic-induced inflammation and injury in the liver. In: McCuskey RS, Earnest DL, eds. Hepatic and Gastrointestinal Toxicology. New York: Pergamon Press, 1997:151-64.
32. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990; 192(2):245-61.
33. Feder LS, Todaro JA, Laskin DL. Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages. J Leukoc Biol 1993; 53(2):126-32.
34. Tsutsui H, Matsui K, Okamura H, et al. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 2000; 174:192-209.
35. Tsutsui H, Adachi K, Seki E, et al. Cytokine-induced inflammatory liver injuries. Curr Mol Med 2003; 3(6):545-59.
36. Kojima Y, Suzuki S, Tsuchiya Y, et al. Regulation of pro-inflammatory and anti-inflammatory cytokine responses by Kupffer cells in endotoxin-enhanced reperfusion injury after total hepatic ischemia. Transpl Int 2003; 16(4):231-40.
37. Dahle MK, Overland G, Myhre AE, et al. The phosphatidylinositol 3-kinase/protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) and IL-10. Infect Immun 2004; 72(10):5704-11.
38. Noji S, Tashiro K, Koyama E, et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990; 173(1):42-7.
39. Takeishi T, Hirano K, Kobayashi T, et al. The role of Kupffer cells in liver regeneration. Arch Histol Cytol 1999; 62(5):413-22.
40. Roth S, Gong W, Gressner AM. Expression of different isoforms of TGF-β and the latent TGF-β binding protein (LTBP) by rat Kupffer cells. J Hepatol 1998; 29(6):915-22.
41. Zhang X, Yu WP, Gao L, et al. Effects of lipopolysaccharides stimulated Kupffer cells on activation of rat hepatic stellate cells. World J Gastroenterol 2004; 10(4):610-3.
42. Seki E, Tsutsui H, Iimuro Y, et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 2005; 41(3):443-50.
43. Duffield JS. The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Lond) 2003; 104(1):27-38.
44. Granado M, Martin AI, Priego T, et al. Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression. J Endocrinol 2006; 188(3):503-11.
45. Abril ER, Simm WM, Earnest DL. Kupffer cell secretion of cytotoxin cytokines is enhanced by hypervitaminosis A. In: Wisse E, Knook DL, Decker K, eds. Cells of the Hepatic Sinusoid. Vol. 2 Rijswijk, The Netherlands: Kupffer Cell Foundation, 1989:73-5.
46. Arthur MJP, Bentley IS, Tanner A, et al. Oxygen-derived free radicals promote hepatic injury in the rat. Gastroenterology 1985; 89(5):1114-22.
47. Shiratori Y, Takikawa H, Kawase T, et al. Superoxide anion generating capacity and lysosomal enzyme activities of Kupffer cells in galactosamine-induced hepatitis. Gastroenterol Jpn 1986; 21(2):135-44.
48. Mochida S, Ogata I, Ohta Y, et al. In situ evaluation of the stimulatory state of hepatic macrophages based on their ability to produce superoxide anions in rats. J Pathol 1989; 158(1):67-71.
49. Bautista AP, Meszaros K, Bojta J, et al. Superoxide anion generation in the liver during the early stages of endotoxemia in rats. J Leukoc Biol 1990; 48(2):123-8.
50. Rogoff TM, Lipsky PE. Antigen presentation by isolated guinea pig Kupffer cells. J Immunol 1980; 124(4):1740-4.
51. Itoh Y, Okanoue T, Morimoto M, et al. Functional heterogeneity of rat liver macrophages:interleukin-1 secretion and Ia antigen expression in contrast with phagocytic activity. Liver 1992; 12(1):26-33.
52. Lohse AW, Knolle PA, Bilo K, et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 1996; 110(4):1175-81.
53. Maemura K, Zheng Q, Wada T, et al. Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells. Immunol Cell Biol 2005; 83(4):336-43.
54. Matsuno K, Nomiyama H, Yoneyama H, et al. Kupffer cell-mediated recruitment of dendritic cells to the liver crucial for a host defense. Dev Immunol 2002; 9(3):143-9.
55. Gardner CR, Heck DE, Yang CS, et al. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology 1998; 27(4 Pt. 2):748-54.
56. Gardner CR, Laskin JD, Dambach DM, et al. Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-α and interleukin-10. Toxicol Appl Pharmacol 2002; 184(1):27-36.
57. Laskin DL. Nonparenchymal cells and hepatotoxicity. Semin Liver Dis 1990; 10(4):293-304.
58. Blazka ME, Wilmer JL, Holladay SD, et al. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 1995; 133(1):43-52.
59. Blazka ME, Elwellk MR, Holladay SD, et al. Histopathology of acetaminophen-induced liver changes: role of interleukin 1α and tumor necrosis factor α. Toxicol Pathol 1996; 24(2):181-9.
60. Chiu H, Brittingham JA, Laskin DL. Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: effects of hemin and biliverdin. Toxicol Appl Pharmacol 2002; 181(2):106-15.
61. Lawson JA, Farhood A, Hopper RD, et al. The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 2000; 54(2):509-16.
62. Hogaboam CM, Bone-Larson CL, Steinhauser ML, et al. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. Am J Pathol 2000; 156(4):1245-52.
63. Nakae D, Yamamoto K, Yoshiji H, et al. Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am J Pathol 1990; 136(4):787-95.
64. Dambach DM, Watson LM, Gray KR, et al. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 2002; 35(5):1093-103.
65. Michael SL, Pumford NR, Mayeux PR, et al. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 1999; 30(1):186-95.
66. Shiratori Y, Tanaka M, Hai K, et al. Role of endotoxin-responsive macrophages in hepatic injury. Hepatology 1990; 11(2):183-92.
67. Ahmad N, Chen LC, Gordon MA, et al. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J Leukoc Biol 2002; 71(6):1005-11.
68. Aono K, Isobe K, Kiuchi K, et al. In vitro and in vivo expression of inducible nitric oxide synthase during experimental endotoxemia: involvement of other cytokines. J Cell Biochem 1997; 65(3):349-58.
69. Ghezzi P, Saccardo B, Bianchi M. Role of reactive oxygen intermediates in the hepatotoxicity of endotoxin. Immunopharmacology 1986; 12(3):241-4.
70. Decker K. Eicosanoids, signal molecules of liver cells. Semin Liver Dis 1985; 5(2):175-90.
71. Keppler D, Hagmann W, Rapp S, et al. The relation of leukotrienes to liver injury. Hepatology 1985; 5(5):883-91.
72. Rodriguez de Turco EB, Spitzer JA. Eicosanoid production in nonparenchymal liver cells isolated from rats infused with E. coli endotoxin. J Leukoc Biol 1990; 48(6):488-94.
73. Mustafa SB, Flickinger BD, Olson MS. Suppression of lipopolysaccharide-induced nitric oxide synthase expression by platelet-activating factor receptor antagonists in the rat liver and cultured rat Kupffer cells. Hepatology 1999; 30(5):1206-14.
74. Thompson WD, Jack AS, Patrick RS. Possible role of macrophages in transient hepatic fibrogenesis induced by acute carbon tetrachloride injury. J Pathol 1980; 130(2):65-73.
75. Orfila C, Lepert JC, Alric L, et al. Expression of TNF-α and immunohistochemical distribution of hepatic macrophage surface markers in carbon tetrachloride-induced chronic liver injury in rats. Histochem J 1999; 31(10):677-85.
76. Camandola S, Aragno M, Cutrin JC, et al. Liver AP-1 activation due to carbon tetrachloride is potentiated by 1,2-dibromoethane but is inhibited by α-tocopherol or gadolinium chloride. Free Radic Biol Med 1999; 26(9/10):1108-16.
77. elSisi AE, Earnest DL, Sipes IG. Vitamin A potentiation of carbon tetrachloride hepatotoxicity: role of liver macrophages and active oxygen species. Toxicol Appl Pharmacol 1993; 119(2):295-301.
78. Chamulitrat W, Blazaka ME, Jordan SJ, et al. Tumor necrosis factor-α and nitric oxide production in endotoxin-primed rats administered carbon tetrachloride. Life Sci 1995; 57(24):2273-80.
79. Morio LA, Chiu H, Sprowles KA, et al. Distinct roles of tumor necrosis factor-α and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol 2001; 172(1):44-51.
80. Katz A, Chebath J, Friedman J, et al. Increased sensitivity of IL-6-deficient mice to carbon tetrachloride hepatotoxicity and protection with an IL-6 receptor-IL-6 chimera. Cytokines Cell Mol Ther 1998; 4(4):221-7.
81. Armendariz-Borunda J, Katai H, Jones CM, et al. Transforming growth factor-β gene expression is transiently enhanced at a critical stage during liver regeneration after CCl4 treatment. Lab Invest 1993; 69(3):283-94.
82. Sipes IG, el Sisi AE, Sim WW, et al. Reactive oxygen species in the progression of CCl4-induced liver injury. Adv Exp Med Biol 1991; 283:489-97.
83. Zhu W, Fung PC. The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl4-induced acute liver injury of mice. Free Radic Biol Med 2000; 29(9):870-80.
84. Thompson K, Maltby J, Fallowfield J, et al. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology 1998; 28(6):1597-606.
85. Kamimura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 1995; 22(4 Pt. 1):1304-9.
86. Bukara M, Bautista AP. Acute alcohol intoxication and gadolinium chloride attenuate endotoxininduced release of CC chemokines in the rat. Alcohol 2000; 20(2):193-203.
87. Yokoyama H, Fukuda M, Okamura Y, et al. Superoxide anion release into the hepatic sinusoid after an acute ethanol challange and its attenuation by Kupffer cell depletion. Alcohol Clin Exp Res 1999; 23(Suppl. 4):71S-5S.
88. Fang C, Lindros KO, Badger TM, et al. Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole. Hepatology 1998; 27(5):1304-10.
89. Yin M, Wheeler MD, Kono H, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999; 117(4):942-52.
90. Spitzer JA, Zheng M, Kolls JK, et al. Ethanol and LPS modulate NF-kappaB activation, inducible NO synthase and COX-2 gene expression in rat liver cells in vivo. Front Biosci 2002; 7:a99-108.
91. Maher JJ. Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of ethanol. Am J Physiol 1995; 269(4 Pt. 1):G518-23.
92. Bautista AP. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastroenterol Hepatol 2000; 15(4):346-56.
93. Afford SC, Fisher NC, Neil DAH, et al. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol 1998; 186(1):82-9.
94. Matsumoto H, Nishitani Y, Minowa Y, et al. Role of Kupffer cells in the release of nitric oxide and change of portal pressure after ethanol perfusion in the rat liver. Alcohol Alcohol 2000; 35(1):31-4.
95. Hoglen NC, Younis HS, Hartley DP, et al. 1,2-Dichlorobenzene-induced lipid peroxidation in male Fischer 344 rats is Kupffer cell dependent. Toxicol Sci 1998; 46(2):376-85.
96. Guanawardhana L, Mobley SA, Sipes IG. Modulation of 1,2-dichlorobenzene hepatotoxicity in the Fischer- 344 rat by a scavanger of superoxide anions and an inhibitor of Kupffer cells. Toxicol Appl Pharmacol 1993; 119(2):205-13.
97. Younis HS, Hoglen NC, Kuester RK, et al. 1,2-Dichlorobenzene-mediated hepatocellular oxidative stress in Fischer-344 and Sprague-Dawley rats. Toxicol Appl Pharmacol 2000; 163(2):141-8.
98. Younis HS, Parrish AR, Sipes IG. The role of hepatocellular oxidative stress in Kupffer cell activation during 1,2-dichlorobenzene-induced hepatotoxicity. Toxicol Sci 2003; 76(1):201-11.
99. Shiratori Y, Hai K, Takada H, et al. Mechanism of accumulation of macrophages in galactosamineinduced liver injury: effect of lipoxygenase inhibitors on chemotaxis of spleen cells. Pathobiology 1992; 60(6):316-21.
100. Jonker AM, Kijkhuis FW, Kroese FG, et al. Immunopathology of acute galactosamine hepatitis in rats. Hepatology 1990; 11(4):622-7.
101. MacDonald JR, Beckstead JH, Smuckler EA. An ultrastructural and histochemical study of the prominent inflammatory response in D(+)-galactosamine hepatotoxicity. Br J Exp Pathol 1987; 68(2):189-99.
102. Shiratori Y, Kawase T, Shiina S, et al. Modulation of hepatotoxicity by macrophages in the liver. Hepatology 1988; 8(4):815-21.
103. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin- induced hepatitis in mice. Biochem Pharmacol 1989; 38(4):627-31.
104. Hishinuma I, Nagakawa J, Hirota K, et al. Involvement of tumor necrosis factor-α in development of hepatic injury in galactosamine-sensitized mice. Hepatology 1990; 12(5):1187-91.
105. Nowak M, Gaines GG, Rosenberg J, et al. LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor. Am J Physiol Regul Integr Comp Physiol 2000; 278(5):R1202-9.
106. Rikans LE, Yamano T. Mechanisms of cadmium-mediated acute hepatotoxicity. J Biochem Mol Toxicol 2000; 14(2):110-7.
107. Yamano T, DeCicco LA, Rikans LE. Attenuation of cadmium-induced liver injury in senecent male Fischer 344 rats: role of Kupffer cells and inflammatory cytokines. Toxicol Appl Pharmacol 2000; 162(1):68-75.
108. Kayama F, Yoshida T, Elwell MR, et al. Role of tumor necrosis factor-alpha in cadmium-induced hepatotoxicity. Toxicol Appl Pharmacol 1995; 131(2):224-34.
109. Przybocki JM, Reuhl KR, Thurman RG, et al. Involvement of nonparenchymal cells in oxygendependent hepatic injury by allyl alcohol. Toxicol Appl Pharmacol 1992; 115(1):57-63.
110. Sneed RA, Buchweitz JP, Jean PA, et al. Pentoxifylline attenuates bacterial lipopolysaccharideinduced enhancement of allyl alcohol hepatotoxicity. Toxicol Sci 2000; 56(1):203-10.
111. Ide M, Yamate J, Machida Y, et al. Emergence of different macrophage populations in hepatic fibrosis following thioacetamide-induced acute hepatocyte injury in rats. J Comp Pathol 2003; 128(1):41-51.
112. Andrés D, Sanchez-Reus I, Bautista M, et al. Depletion of Kupffer cell function by gadolinium chloride attenuates thioacetamide-induced hepatotoxicity. Expression of metallothionein and HSP70. Biochem Pharmacol 2003; 66(6):917-26.
113. Novosyadlyy R, Dargel R, Scharf JG. Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats. Growth Horm IGF Res 2005; 15(5):313-23.
114. Laskin DL, Robertson FM, Pilaro AM, et al. Activation of liver macrophages following phenobarbital treatment of rats. Hepatology 1988; 8(5):1051-5.
115. Arthur MJP, Kowalski-Sanders P, Wright R. Corynebacterium parvum-elicited hepatic macrophages demonstrate enhanced respiratory burst activity compared with resident Kupffer cells in the rat. Gastroenterology 1986; 91(1):174-81.
116. Laskin DL, Gardner CR. Nonparenchymal cells, inflammatory macrophages, and hepatotoxicity. In: Kaplowitz N, DeLeve LD, eds. Drug-Induced Liver Disease. New York: Marcel Dekker, 2003:183-211.
117. Armendariz-Borunda J, Seyer JM, Postlethwaite AE, et al. Kupffer cells from carbon tetrachlorideinjured rat livers produce chemotactic factors for fibroblasts and monocytes: the role of tumor necrosis factor-alpha. Hepatology 1991; 14(5):895-900.
118. Nagy LE. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med (Maywood) 2003; 228(8):882-90.
119. Laskin DL, Pendino KJ. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 1995; 35:655-77.
120. Sudhir S, Budhiraja RD. Comparison of the protective effect of Withaferin-A and hydrocortisone against CCl4 induced hepatotoxicity in rats. Indian J Physiol Pharmacol 1992; 36(2):127-9.
121. Ben-Zvi Z, Weissman-Teitellman B, Katz S, et al. Acetaminophen hepatotoxicity: is there a role for prostaglandin synthesis? Arch Toxicol 1990; 64(4):299-304.
122. Li G, Liu Y, Tzeng NS, et al. Protective effect of dextromethorphan against endotoxic shock in mice. Biochem Pharmacol 2005; 69(2):233-40.
123. Edwards MJ, Keller BJ, Kauffman FC, et al. The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol Appl Pharmacol 1993; 119(2):275-9.
124. Laskin DL, Gardner CR, Price VF, et al. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 1995; 21(4):1045-50.
125. Stenger RJ, Petrelli M, McPath DCP, et al. Modification of carbon tetrachloride hepatoxicity by prior loading of the reticuloendothelial system with carbon particles. Am J Pathol 1969; 57(3):689-97.
126. Deaciuc IV, Bagby GJ, Niesman MR, et al. Modulation of hepatic sinusoidal endothelial cell function by Kupffer cells: an example of intercellular communication in the liver. Hepatology 1994; 19(2):464-70.
127. Goldin RD, Ratnayaka ID, Breach CS, et al. Role of macrophages in acetaminophen (paracetamol)- induced hepatotoxicity. J Pathol 1996; 179(4):432-5.
128. Ishiyama H, Ogino K, Hobara T. Kupffer cells in rat liver injury induced by diethyldithiocarbamate. Eur J Pharmacol 1995; 292(2):135-41.
129. Iimuro Y, Yamamoto M, Kohno H, et al. Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats-analysis of mechanisms of lethality in endotoxemia. J Leukoc Biol 1994; 55(6):723-8.
130. Al-Tuwaijri A, Akdamar K, Di Luzio NR. Modification of galactosamine-induced liver injury in rats by reticuloendothelial system stimulation or depression. Hepatology 1981; 1(2):107-13.
131. Ide M, Kuwamura M, Kotani T, et al. Effects of gadolinium chloride (GdCl3) on the appearance of macrophage populations and fibrogenesis in thioacetamide-induced rat hepatic lesions. J Comp Pathol 2005; 133(2-3):92-102.
132. He Q, Kim J, Sharma RP. Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride. Toxicology 2005; 207(1):137-47.
133. Galanos C, Freudenberg MA, Reuter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci (USA) 1979; 76(11):5939-43.
134. Sauer JM, Hooser SB, Badger DA, et al. Alterations in chemically induced tissue injury related to alltrans- retinol pretreatment in rodents. Drug Metabol Rev 1995; 27(1-2):299-323.
135. Sauer JM, Sipes IG. Modulation of chemical-induced lung and liver toxicity by all-trans-retinol in the male Sprague-Dawley rat. Toxicology 1995; 105(2-3):237-49.
136. Ju C, Reilly TP, Bourdi M, et al. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol 2002; 15(12):1504-13.
137. Olthoff KM. Molecular pathways of regeneration and repair after liver transplantation. World J Surg 2002; 26(7):831-7.
138. Roggin KK, Papa EF, Kurkchubasche AG, et al. Kupffer cell inactivation delays repair in a rat model of reversible biliary obstruction. J Surg Res 2000; 90(2):166-73.
139. Taub R, Bansal M, Lei W. Roles of cytokines and growth factors in liver regeneration, repair, and fibrosis after liver injury. In: Kaplowitz N, DeLeve LD, eds. Drug-Induced Liver Disease. New York:Marcel Dekker, 2003:213-25.
140. Duffield JS, Forbes SJ, Constandinou CM, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115(1):56-65.
141. Blazka ME, Germolec DR, Simeonova P, et al. Acetaminophen-induced hepatotoxicity is associated with early changes in NF-κB and NF-IL6 DNA binding activity. J Inflamm 1995; 47(3):138-50.
142. Chiu H, Gardner CR, Dambach DM, et al. Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense. Am J Physiol Gastrointest Liver Physiol 2003; 285(5):G959-66.
143. Dambach DM, Durham SK, Laskin JD, et al. Distinct roles of NF-κB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity. Toxicol Appl Pharmacol 2006; 211(2):157-65.
144. Ahmad N, Chen C, Martey CA, et al. Acute endotoxemia is associated with increased STAT1 and NF-κB nuclear binding activity in hepatic macrophages and endothelial cells. Toxicol Sci 2000; 54(1):140.
145. Fox ES, Cantrell CH, Leingang KA. Inhibition of the Kupffer cell inflammatory response by acute ethanol: NF-κB activation and subsequent cytokine production. Biochem Biophys Res Commun 1996; 225(1):134-40.
146. Essani NA, McGuire GM, Manning AM, et al. Endotoxin-induced activation of the nuclear transcription factor κB and expression of e-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells. J Immunol 1996; 156(8):2956-63.
147. Gruebele A, Zawaski K, Kaplan D, et al. Cytochrome P4502E1- and cytochrome P4502B1/2B2- catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-κB transcription factor levels. Drug Metabol Dispos 1996; 24(1):15-22.
148. Nanji AA, Jokelainen K, Rahemtulla A, et al. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 1999; 30(4):934-43.
149. Taniguchi M, Takeuchi T, Nakatsuka R, et al. Molecular process in acute liver injury and regeneration induced by carbon tetrachloride. Life Sci 2004; 75(13):1539-49.
150. McMullen MR, Pritchard MT, Wang Q, et al. Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology 2005; 128(7):2066-76.
151. Celec P. Nuclear factor kappa B-molecular biomedicine: the next generation. Biomed Pharmacother 2004; 58(6-7):365-71.
152. Liu SL, Degli Esposti S, Yao T, et al. Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology 1995; 22(5):1474-81.
153. Kim SH, Chu HJ, Kang DH, et al. NF-kappa B binding activity and cyclooxygenase-2 expression in persistent CCl4-treated rat liver injury. J Korean Med Sci 2002; 17(2):193-200.
154. Chaisson ML, Brooling JT, Ladiges W, et al. Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 2002; 110(2):193-202.
155. Maeda S, Kamata H, Luo JL, et al. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005; 121(7):977-90.
156. Blazka ME, Bruccoleri A, Simeonova P, et al. Acetaminophen-induced hepatotoxicity is associated with early changes in AP-1 DNA binding activity. Res Commun Mol Pathol Pharmacol 1996; 92(3):259-73.
157. Tran-Thi TA, Decker K, Baeuerle P. Differential activation of transcription factors NF-κB and AP-1 in rat liver macrophages. Hepatology 1995; 22(2):613-9.
158. Liu J, Kadiiska MB, Corton JC, et al. Acute cadmium exposure induces stress-related gene expression in wild-type and metallothionein-I/II-null mice. Free Radic Biol Med 2002; 32(6):525-35.
159. Schiaffonati L, Tiberio L. Gene expression in liver after toxic injury: analysis of heat shock response and oxidative stree-inducible genes. Liver 1997; 17(4):183-91.
160. Wang XD, Liu C, Chung J, et al. Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-Jun and c-Fos) expression in rat liver. Hepatology 1998; 28(3):744-50.
161. Chiu H, Gardner CR, Dambach DM, et al. Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice. Toxicol Appl Pharmacol 2003; 193(2):218-27.
162. Gashler A, Sukhatme VP. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 1995; 50:191-224.
163. Feng JM, Shi JQ, Liu YS. The effect of lipopolysaccharides on the expression of CD14 and TLR4 in rat Kupffer cells. Hepatobiliary Pancreat Dis Int 2003; 2(2):265-9.
164. Chen LC, Laskin DL, Laskin JD. Regulation of inflammatory mediator production in the liver during acute endotoxemia. Toxicologist 2006; 90(1):349.
165. Gunawan BK, Liu ZX, Han D, et al. c-Jun-N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 2006; 131(1):165-78.
166. Klintman D, Li X, Santen S, et al. p38 mitogen-activated protein kinase-dependent chemokine production, leukocyte recruitment, and hepatocellular apoptosis in endotoxemic liver injury. Ann Surg 2005; 242(6):830-8 (discussion 838-839).
167. Cheng YJ, Liu MY. Modulation of tumor necrosis factor-alpha and oxidative stress through protein kinase C and P42/44 mitogen-activated protein kinase in lead increases lipopolysaccharide-induced liver damage in rats. Shock 2005; 24(2):188-93.
168. Enomoto K, Nishikawa Y, Omori Y, et al. Cell biology and pathology of liver sinusoidal endothelial cells. Med Electron Microsc 2004; 37(4):208-15.
169. van Oosten M, van Amersfoort ES, van Berkel TJ, et al. Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res 2001; 7(5):381-4.
170. Praaning-van Dalen DP, De Leeuw AM, Brower A, et al. Rat liver endothelial cells have a greater capacity that Kupffer cells to endocytose N-acetylglucosamine- and mannose-terminated glycoproteins. Hepatology 1987; 7(4):672-9.
171. Dini L, Lentini A, Diez GD, et al. Phagocytosis of apoptotic bodies by liver endothelial cells. J Cell Sci 1995; 108(Pt 3):967-73.
172. Kosugi I, Muro H, Shirasawa H, et al. Endocytosis of soluble IgG immune complex and its transport to lysosomes in hepatic sinusoidal endothelial cells. J Hepatol 1992; 16(1-2):106-14.
173. Smedsrod B, Pertoft H, Gustanfson S, et al. Scavenger functions of the liver endothelial cell. Biochem J 1990; 266(2):313-27.
174. Oynebraten I, Hansen B, Smedsrod B, et al. Serglycin secreted by leukocytes is efficiently eliminated from the circulation by sinusoidal scavenger endothelial cells in the liver. J Leukoc Biol 2000; 67(2):183-8.
175. Zhou B, Oka JA, Singh A, et al. Purification and subunit characterization of the rat liver endocytic hyaluronan receptor. J Biol Chem 1999; 274(48):33831-4.
176. Yoshioka T, Yamamoto K, Kobashi H, et al. Receptor-mediated endocytosis of chemically modified albumins by sinusoidal endothelial cells and Kupffer cells in rat and human liver. Liver 1994; 14(3):129-37.
177. Esbach S, Stins MF, Brouwer A, et al. Morphological characterization of scavenger receptormediated processing of modified lipoproteins by rat liver endothelial cells. Exp Cell Res 1994; 210(1):62-70.
178. Duryee MJ, Freeman TL, Willis MS, et al. Scavenger receptors on sinusoidal liver endothelial cells (SECs) are involved in the uptake of Aldehyde-modified proteins. Mol Pharmacol 2005; 68(5):1423-30.
179. Nakajou K, Horiuchi S, Sakai M, et al. CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells. J Biochem (Tokyo) 2005; 137(5):607-16.
180. Hansen B, Longati P, Elvevold K, et al. Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding. Exp Cell Res 2005; 303(1):160-73.
181. Steffan A-M, Gendrault J-L, McCuskey RS, et al. Phagocytosis, an unrecognized property of murine endothelial liver cells. Hepatology 1986; 6(5):830-6.
182. Shiratori Y, Jinʼnai H, Teraoka H, et al. Phagocytic properties of hepatic endothelial cells and splenic macrophages compensating for a decreased phagocytic function of Kupffer cells in the chronically ethanol-fed rats. Exp Cell Biol 1989; 57(6):300-9.
183. Bogers WMJM, Stad RK, Janssen DJ, et al. Kupffer cell depletion in vivo results in clearance of largesized IgA aggregates in rats by liver endothelial cells. Clin Exp Immunol 1991; 85(1):128-36.
184. Hashimoto N, Watanabe T, Shiratori Y, et al. Prostanoid secretion by rat hepatic sinusoidal endothelial cells and its regulation by exogenous adenosine triphosphate. Hepatology 1995; 21(6):1713-8.
185. Gardner CR, Laskin JD, Laskin DL. Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells. J Leukoc Biol 1993; 53(2):190-6.
186. Spolarics Z. Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells. Am J Physiol 1996; 270(4 Pt. 1):G660-6.
187. Misquith S, Wattiaux-De Coninck S, Wattiaux R. Intracellular degradation by liver endothelial cells. Mol Cell Biochem 1989; 91(1-2):63-74.
188. Eakes AT, Olson MS. Regulation of endothelin synthesis in hepatic endothelial cells. Am J Physiol 1998; 274(6 Pt 1):G1068-76.
189. Mizoguchi Y, Ichikawa Y, Kioka K, et al. Effects of arachidonic acid metabolites and interleukin-1 on platelet activating factor production by hepatic sinusoidal endothelial cells from mice. J Gastroenterol Hepatol 1991; 6(3):283-8.
190. Arii S, Imamura M. Physiological role of sinusoidal endothelial cells and Kupffer cells and their implications in the pathogenesis of liver injury. J Hepatobiliary Pancreat Surg 2000; 7(1):40-8.
191. Ohira H, Abe K, Yokokawa J, et al. Adhesion molecules and CXC chemokines in endotoxin-induced liver injury. Fukushima J Med Sci 2003; 49(1):1-13.
192. Komatsu Y, Shiratori Y, Kawase T, et al. Role of polymorphonuclear leukocytes in galactosamine hepatitis: mechanism of adherence to hepatic endothelial cells. Hepatology 1994; 20(6):1548-56.
193. Scoazec JY, Feldmann G. The cell adhesion molecules of hepatic sinusoidal endothelial cells. J Hepatol 1994; 20(2):296-300.
194. Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev 2000; 174:21-34.
195. Knolle PA, Limmer A. Control of immune responses by savenger liver endothelial cells. Swiss Med Wkly 2003; 133(37-38):501-6.
196. Sarphie G, D’Souza NB, Van Thiel DH, et al. Dose- and time-dependent effects of ethanol on functional and structural aspects of the liver sinusoid in the mouse. Alcohol Clin Exp Res 1997; 21(6):1128-36.
197. Rachfal AW, Brigstock DR. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 2003; 26(1):1-9.
198. Deaciuc IV, Alappat JM, D’Souza NB. Effect of acute and chronic alcohol administration to rats on the expression of interleukin-6 cell-surface receptors of hepatic parenchymal and nonparenchymal cells. Alcohol Clin Exp Res 1994; 18(5):1207-14.
199. Deaciuc IV, D’Souza NB, Spitzer JJ. Tumor necrosis factor-alpha cell-surface receptors of liver parenchymal and nonparenchymal cells during acute and chronic alcohol administration to rats. Alcohol Clin Exp Res 1995; 19(2):332-8.
200. Nanji AA, Griniuviene B, Yacoub LK, et al. Intercellular adhesion molecule-1 expression in experimental alcoholic liver disease: relationship to endotoxemia and TNF alpha messenger RNA. Exp Mol Pathol 1995; 62(1):42-51.
201. Nanji AA, Tahan SR. Association between endothelial cell proliferation and pathologic changes in experimental alcoholic liver disease. Toxicol Appl Pharmacol 1996; 140(1):101-7.
202. Wisse E, Braet F, Luo D, et al. Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol 1996; 24(1):100-11.
203. van Oosten M, van de Bilt E, de Vries HE, et al. Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology 1995; 22(5):1538-46.
204. Mousa SA. Expression of adhesion molecules during cadmium hepatotoxicity. Life Sci 2004; 75(1):93-105.
205. Edwards S, Lalor PF, Nash GB, et al. Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes. Hepatology 2005; 41(3):451-9.
206. Uhrig A, Banafsche R, Kremer M, et al. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J Leukoc Biol 2005; 77(5):626-33.
207. Thiele GM, Duryee MJ, et al. Rat sinusoidal liver endothelial cells (SECs) produce pro-fibrotic factors in response to adducts formed from the metabolites of ethanol. Biochem Pharmacol 2005; 70(11):1593-600.
208. Jarnagin WR, Rockey DC, Koteliansky VE, et al. Expression of variant fibronectins in wound healing:cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994; 127(6 Pt 2):2037-48.
209. George J, Wang SS, Sevcsik AM, et al. Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform. Am J Pathol 2000; 156(1):115-24.
210. Bautista AP. Chronic alcohol intoxication primes Kupffer cells and endothelial cells for enhanced CC-chemokine production and concomitantly suppresses phagocytosis and chemotaxis. Front Biosci 2002; 7:a117-25.
211. Blomhoff R, Wake K. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J 1991; 5(3):271-7.
212. Hendriks HF, Verhoofstad WA, Brouwer A, et al. Perisinusoidal fat-storing cells are the main vitamin A storage cells in rat liver. Exp Cell Res 1985; 160(1):138-49.
213. Ogata I, Mochida S, Tomiya T, et al. Minor contribution of hepatocytes to collagen production in normal and early fibrotic rat livers. Hepatology 1991; 14(2):361-7.
214. Shiratori Y, Ichida T, Geerts A, et al. Modulation of collagen synthesis by fat-storing cells, isolated from CCl4- or vitamin A- treated rats. Dig Dis Sci 1987; 32(11):1281-9.
215. Arthur MJ, Stanley A, Iredale JP, et al. Secretion of 72 kDa type IV collagnease/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J 1992; 287(Pt 3):701-7.
216. Friedman SL. Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis 1990; 10(1):20-9.
217. Friedman SL, Roll FJ, Boyles JK, et al. Hepatic lipocytes: the principle collagen-producing cells of normal rat liver. Proc Natl Acad Sci (USA) 1985; 82(24):8681-5.
218. French SW, Takahashi H, Wong K, et al. Ito cell activation induced by chronic ethanol feeding in the presence of different dietary fats. Alcohol Alcohol Suppl 1991; 1:357-61.
219. Gressner AM. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int Suppl 1996; 54:S39-45.
220. Kim KY, Choi I, Kim SS. Progression of hepatic stellate cell activation is associated with the level of oxidative stress rather than cytokines during CCl4-induced fibrogenesis. Mol Cell 2000; 10(3):289-300.
221. Ikeda K, Wakahara T, Wang YQ, et al. In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. Hepatology 1999; 29(6):1760-7.
222. Friedman SL. Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol 1997; 32(3):424-30.
223. Knittel T, Dinter C, Kobold D, et al. Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am J Pathol 1999; 154(1):153-67.
224. Hellerbrand C, Wang SC, Tsukamoto H, et al. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 1996; 24(3):670-6.
225. Schieferdecker HL, Schlaf G, Koleva M, et al. Induction of functional anaphylatoxin C5a receptors on hepatocytes by in vivo treatment of rats with IL-6. J Immunol 2000; 164(10):5453-8.
226. Gandhi CR, Uemura T, Kuddus RH. Endotoxin causes up-regulation of endothelin receptors in cultured hepatic stellate cells via nitric oxide-dependent and -independent mechanisms. Br J Pharmacol 2000; 131(2):319-27.
227. Fennekohl A, Schieferdecker HL, Jungermann K, et al. Differential expression of prostanoid receptors in hepatocytes. Kupffer cells, sinusoidal endothelial cells and stellate cells of rat liver. J Hepatol 1999; 30(1):38-47.
228. Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res 1999; 23(5):911-6.
229. Wong L, Yamasaki G, Johnson RJ, et al. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 1994; 94(4):1563-9.
230. Helyar L, Bundschuh DS, Laskin JD, et al. Hepatic fat storing cells produce nitric oxide and hydrogen peroxide in response to bacterially-derived lipopolysaccharide. In: Knook DL, Decker K et al, eds. Cells of the Hepatic Sinusoid, Vol. 4. Amsterdam: Kupffer Cell Foundation, 1993:394-6.
231. Helyar L, Bundschuh DS, Laskin JD, et al. Induction of hepatic Ito cell nitric oxide production by acute endotoxemia. Hepatology 1994; 12(6):1509-15.
232. Athari A, Hanecke K, Jungermann K. Prostaglandin F2 alpha and D2 release from primary Ito cell cultures after stimulation with noradrenaline and ATP but not adenosine. Hepatology 1994; 20(1 Pt 1):142-8.
233. Xu Y, Rojkind M, Czaja MJ. Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells. Gastroenterology 1996; 110(6):1870-7.
234. Knittel T, Janneck T, Muller L, et al. Transforming growth factor beta 1-regulated gene expression of Ito cells. Hepatology 1996; 24(2):352-60.
235. Ramadori G, Knittel T, Odenthal M, et al. Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterology 1992; 103(4):1313-21.
236. Davis BH, Kramer RT, Davidson NO. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J Clin Invest 1990; 86(6):2062-70.
237. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000; 21(3):49-98.
238. Britton RS, Bacon BR. Intracellular signaling pathways in stellate cell activation. Alcohol Clin Exp Res 1999; 23(5):922-5.
239. Friedman SL. Stellate cell activation in alcoholic fibrosis-an overview. Alcohol Clin Exp Res 1999; 23(5):904-10.
240. Reeves HL, Friedman SL. Activation of hepatic stellate cells-a key issue in liver fibrosis. Front Biosci 2002; 7:d808-26.
241. Higuchi H, Gores GJ. Mechanisms of liver injury: an overview. Curr Mol Med 2003; 3(6):483-90.
242. Zhan SS, Jiang JX, Wu J, et al. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology 2006; 43(3):435-43.
243. Prosser CC, Yen RD, Wu J. Molecular therapy for hepatic injury and fibrosis: where are we? World J Gastroenterol 2006; 12(4):509-15.
244. Sprenger H, Kaufmann A, Garn H, et al. Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells. J Hepatol 1999; 30(1):88-94.
245. Wiltrout RH. Regulation and antimetastatic functions of liver-associated natural killer cells. Immunol Rev 2000; 174:63-76.
246. Morris MA, Ley K. Trafficking of natural killer cells. Curr Mol Med 2004; 4(4):431-8.
247. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002; 2(8):557-68.
248. Emoto M, Miyamoto M, Yoshizawa I, et al. Critical role of NK cells rather than V alpha 14(+)NKT cells in lipopolysaccharide-induced lethal shock in mice. J Immunol 2002; 169(3):1426-32.
249. Takeda K, Hayakawa Y, Van Kaer L, et al. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000; 97(10):5498-503.
250. Liu ZX, Govindarajan S, Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004; 127(6):1760-74.
251. Larrick JW, Kunkel SL. The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response. Pharm Res 1988; 5(3):129-39.
252. Whicher JT, Evans SW. Cytokines in disease. Clin Chem 1990; 36(7):1269-81.
253. Cerami A. Inflammatory cytokines. Clin Immunol Immunopathol 1992; 62(1 Pt 2):S3-10.
254. Punjabi CJ, Laskin JD, Hwang S-M, et al. Enhanced production of nitric oxide by bone marrow cells and increased sensitivity to macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF after benzene treatment of mice. Blood 1994; 83(11):3255-62.
255. Lavnikova N, Drapier J-C, Laskin DL. A single exogenous stimulus activates rat macrophages for nitric oxide production and cytotoxicity. J Leukoc Biol 1993; 54(4):322-8.
256. Sharma RJ, Macallan DC, Sedgwick P, et al. Kinetics of endotoxin-induced acute-phase protein gene expression and its modulation by TNF-α monoclonal antibody. Am J Physiol 1992; 262(5 Pt 2):R786-93.
257. Sujita K, Okuno F, Tanaka Y, et al. Effect of interleukin 1 (IL-1) on the level of cytochrome P-450 involving IL-1 receptor on the isolated hepatocytes of rat. Biochem Biophys Res Commun 1990; 168(3):1217-22.
258. Curran RD, Billiar TR, Stuehr DJ, et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 1990; 212(4):462-9.
259. Wang JH, Redmond HP, Watson RW, et al. Role of lipopolysaccharide and tumor necrosis factor-α in induction of hepatocyte necrosis. Am J Physiol 1995; 269(2 Pt. 1):G297-304.
260. Leist M, Gantner F, Bohlinger I, et al. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 1994; 153(4):1778-88.
261. Schwabe RF, Brenner DA. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006; 290(4):G583-9.
262. Satoh M, Yamazaki M. Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor beta and interleukin 6. J Cell Physiol 1992; 150(1):134-9.
263. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003; 10(1):45-65.
264. Beyer HS, Theologides A. Tumor necrosis factor-alpha is a direct hepatocyte mitogen in the rat. Biochem Mol Biol Int 1993; 29(1):1-4.
265. Yamada Y, Kirillova I, Peschon JJ, et al. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997; 94(4):1441-6.
266. Gardner CR, Laskin JD, Dambach DM, et al. Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol Appl Pharmacol 2003; 192(2):119-30.
267. McClain CJ, Barve S, Deaciuc IV, et al. Cytokines in alcoholic liver disease. Semin Liver Dis 1999; 19(2):205-19.
268. Scotte M, Hiron M, Masson S, et al. Differential expression of cytokine genes in monocytes, peritoneal macrophages and liver following endotoxin- or turpentine-induced inflammation in rat. Cytokine 1996; 8(2):115-20.
269. Horn TL, O’Brien TD, Schook LB, et al. Acute hepatotoxicant exposure induces TNFR-mediated hepatic injury and cytokine/apoptotic gene expression. Toxicol Sci 2000; 54(1):262-73.
270. Wang J, Wendel A. Studies on the hepatotoxicity of galactosamine/endotoxin or galactosamine/TNF in the perfused mouse liver. Biochem Pharmacol 1990; 39(2):267-70.
271. Schook LB, Lockwood JF, Yang SD, et al. Dimethylnitrosamine (DMN)-induced IL-1 beta, TNFalpha, and IL-6 inflammatory cytokine expression. Toxicol Appl Pharmacol 1992; 116(1):110-6.
272. Bourdi M, Masubuchi Y, Reilly TP, et al. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 2002; 35(2):289-98.
273. Ishida Y, Kondo T, Ohshima T, et al. A pivotal involvement of IFN-γ in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 2002; 16(10):1227-36.
274. Shedlofsky SI, McClain CJ. Hepatic dysfunction due to cytokines. In: Kimball ES, ed. Cytokines and Inflammation. Boca Raton, FL: CRC Press, 1991:235-73.
275. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989; 44:153-205.
276. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234(4775):470-4.
277. Fiedler VB, Loof I, Sander E, et al. Monoclonal antibody to tumor necrosis factor-alpha prevents lethal endotoxin sepsis in adult rhesus monkeys. J Lab Clin Med 1992; 120(4):574-88.
278. Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 1995; 108(6):1849-54.
279. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77(8):1627-52.
280. Josephs MD, Solorzano CC, Taylor M, et al. Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1ra. Am J Physiol Regul Integr Comp Physiol 2000; 278(4):R824-30.
281. Iimuro Y, Gallucci RM, Luster MI, et al. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997; 26(6):1530-7.
282. Yamada Y, Fausto N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol 1998; 152(6):1577-89.
283. Cuzzocrea S, de Sarro G, Constantino G, et al. Role of interleukin-6 in a non-septic shock model induced by zymosan. Eur Cytokine Netw 1999; 10(2):191-203.
284. Kovalovich K, DeAngelis PA, Li W, et al. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000; 31(1):149-59.
285. Saile B, Matthes N, Knittel T, et al. Transforming growth factor-β and tumor necrosis factor-α inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology 1999; 30(1):196-202.
286. Dooley S, Delvoux B, Lahme B, et al. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 2000; 31(5):1094-106.
287. Jarvelainen HA, Fang C, Ingelman-Sundberg M, et al. Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines. Hepatology 1999; 29(5):1503-10.
288. Hellerbrand C, Stefanovic B, Giordano F, et al. The role of TGFβ1 in initiating hepatic stellate cell activation in vivo. J Hepatol 1999; 30(1):77-87.
289. Schnabl B, Kweon YO, Frederick JP, et al. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 2001; 34(1):89-100.
290. Feng L. Role of chemokines in inflammation and immunoregulation. Immunol Res 2000; 21(2-3):203-10.
291. Czaja MJ, Geerts A, Xu J, et al. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol 1994; 55(1):120-6.
292. Ohkubo K, Masumoto T, Horiike N, et al. Induction of CINC (interleukin-8) production in rat liver by non-parenchymal cells. J Gastroenterol Hepatol 1998; 13(7):696-702.
293. Kopydlowski KM, Salkowski CA, Cody MJ, et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 1999; 163(3):1537-44.
294. Zhang P, Xie M, Zagorski J, et al. Attenuation of hepatic neutrophil sequestration by anti-CINC antibody in endotoxic rats. Shock 1995; 4(4):262-8.
295. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, et al. Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 2001; 167(1):399-406.
296. Rai RM, Loffreda S, Karp CL, et al. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology 1997; 25(4):889-95.
297. Zisman DA, Kunkel SL, Strieter RM, et al. MCP-1 protects mice in lethal endotoxemia. J Clin Invest 1997; 99(12):2832-6.
298. Gardner CR, Laskin DL. Protective and pathologic roles of nitric oxide in tissue injury. In: Laskin JD, Laskin DL, eds. Cellular and Molecular Biology of Nitric Oxide. New York: Marcel Dekker, 1999:225-46.
299. Shiratori Y, Takada H, Hai K, et al. Generation of chemotactic factor by hepatocytes isolated from chronically ethanol-fed rats. Dig Dis Sci 1992; 37(5):650-8.
300. Laskin DL, Pilaro AM, Ji S. Potential role of macrophages in acetaminophen hepatotoxicity, II. Mechanisms of macrophage accumulation and activation. Toxicol Appl Pharmacol 1986; 86(2):216-26.
301. Mawet E, Shiratori Y, Hikiba Y, et al. Cytokine-induced neutrophil chemoattractant release from hepatocytes is modulated by Kupffer cells. Hepatology 1996; 23(2):353-8.
302. Thornton AJ, Ham J, Kunkel SL. Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. Hepatology 1991; 14(6):1112-22.
303. Louis H, Van Laethem J-L, Wu W, et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998; 28(6):1607-15.
304. Matsukawa A, Hoagboam CM, Lukacs NW, et al. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J Immunol 2000; 164(5):2738-44.
305. Minty A, Chalon P, Derocq J-M, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362(6417):248-50.
306. de Waal Malefyt R, Figdor CG, Huijbens RG, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993; 151(11):6370-81.
307. Loyer P, Ilyin G, Abdel-Razzak Z, et al. Interleukin 4 inhibits the production of some acute-phase proteins by human hepatocytes in primary culture. FEBS Lett 1993; 336(2):215-20.
308. Sugimoto R, Enjoji M, Nakamuta M, et al. Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int 2005; 25(2):420-8.
309. Gabay C, Porter B, Guenette D, et al. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1 beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells:differential effect on C-reactive protein production. Blood 1999; 93(4):1299-307.
310. Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood 1984; 64(5):959-66.
311. Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219(1):1-14.
312. Rubin R, Farber JL. Mechanisms of the killing of cultured hepatocytes with hydrogen peroxide. Arch Biochem Biophys 1984; 228(2):450-9.
313. Sevanian A, Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr 1985; 5:365-90.
314. Towner RA, Reinke LA, Janzen EG, et al. In vivo magnetic resonance imaging study of Kupffer cell involvement in CCl4-induced hepatotoxicity in rats. Can J Physiol Pharmacol 1994; 72(5):441-6.
315. Amimoto T, Matsura T, Koyama SY, et al. Acetaminophen-induced hepatic injury in mice: the role of lipid peroxidation and effects of pretreatment with coenzyme Q10 and alpha-tocopherol. Free Radic Biol Med 1995; 19(2):169-76.
316. Sugino K, Dohi K, Yamada K, et al. Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of antioxidants. Surgery 1989; 105(2 Pt 1):200-6.
317. Nussler AK, Beger H-G, Liu ZZ, et al. Nitric oxide, hepatocytes and inflammation. Res Immunol 1995; 146(9):671-7.
318. Milbourne EA, Bygrave FL. Does nitric oxide play a role in liver function? Cell Signal 1995; 7(4):313-8.
319. Losser M-R, Payen D. Mechanisms of liver damage. Sem Liver Dis 1996; 16(4):357-67.
320. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43(2):109-42.
321. Lavnikova N, Lakhotia A, Patel N, et al. Cytostasis is required for IL-1 induced nitric oxide production in transformed hamster fibroblasts. J Cell Physiol 1996; 169(3):532-7.
322. Laskin DL, Rodriguez del Valle M, Heck DE, et al. Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased nitric oxide synthase gene expression. Hepatology 1995; 22(1):223-34.
323. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 1995; 57:737-69.
324. Hodgson PD, Renton KW. The role of nitric oxide generation in interferon-evoked cytochrome P450 down-regulation. Int J Immunopharmacol 1995; 17(12):995-1000.
325. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15:323-50.
326. Lavnikova N, Burdelya L, Lakhotia A, et al. Macrophage and interleukin-1 induced nitric oxide production and cytostasis in hamster tumor cells varying in malignant potential. J Leukoc Biol 1997; 61(4):452-8.
327. Beckman J. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 1991; 15(1):53-9.
328. Beckman JS, Crow JP. Pathological implications of nitric, superoxide and peroxynitrite formation. Biochem Soc Trans 1993; 21(2):330-4.
329. Freeman B. Free radical chemistry of nitric oxide. Looking at the dark side. Chest 1994; 105(Suppl. 3):79S-84.
330. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271(5 Pt. 1):C1424-37.
331. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite oxidation of sulfhydrals. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266(7):4244-50.
332. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288(2):481-7.
333. Lin KT, Xue JY, Nomen M, et al. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 1995; 270(28):16487-90.
334. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992; 298(2):431-7.
335. Rockey DC, Chung JJ. Regulation of inducible nitric oxide synthase and nitric oxide during hepatic injury and fibrogenesis. Am J Physiol 1997; 273(1 Pt. 1):G124-30.
336. Spitzer JA, Spitzer JJ. Lipopolysaccharide tolerance and ethanol modulate hepatic nitric oxide production in a gender-dependent manner. Alcohol 2000; 21(1):27-35.
337. Hinson JA, Pike SL, Pumford NR, et al. Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice. Chem Res Toxicol 1998; 11(6):604-7.
338. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26(1):48-57.
339. Ialenti A, Ianaro A, Moncada S, et al. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992; 211(2):177-82.
340. Harbrecht BG, Billiar TR, Stadler J, et al. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol 1992; 52(4):390-4.
341. Muriel P. Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Biochem Pharmacol 1998; 56(6):773-9.
342. Taylor BS, Alarcon LH, Billiar TR. Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry (Mosc) 1998; 63(7):766-81.
343. vom Dahl S, Hallbrucker C, Lang F, et al. Role of eicosanoids, inositol phosphates and extracellular Ca2+ in cell-volume regulation of rat liver. Eur J Biochem 1991; 198(1):73-83.
344. Ogle CK, Wu JZ, Alexander JW, et al. The effects of in vivo administration of endotoxin on the functions and interaction of hepatocytes and Kupffer cells. Prostaglandins 1991; 41(2):169-83.
345. Enomoto N, Ikejima K, Yamashina S, et al. Kupffer cell-derived prostaglandin E2 is involved in alcohol-induced fat accumulation in rat liver. Am J Physiol Gastrointest Liver Physiol 2000; 279(1):G100-6.
346. Horton AA, Wood JM. Effects of inhibitors of phospholipase A2, cyclooxygenase and thromboxane synthase on paracetamol hepatotoxicity in the rat. Eicosanoids 1989; 2(2):123-9.
347. Mancuso G, Cusumano V, Cook JA, et al. Efficacy of tumor necrosis factor alpha and eicosanoid inhibitors in experimental models of neonatal sepsis. FEMS Immunol Med Microbiol 1994; 9(1):49-54.
348. Shiratori Y, Tanaka M, Umihara J, et al. Leukotriene inhibitors modulate hepatic injury induced by lipopolysaccharide-activated macrophages. J Hepatol 1990; 10(1):51-61.
349. Tiegs G, Wendel A. Leukotriene-mediated liver injury. Biochem Pharmacol 1988; 37(13):2569-73.
350. Casey LC, Fletcher JR, Zmudka MI, et al. The role of thromboxane in primate endotoxin shock. J Surg Res 1985; 39(2):140-9.
351. Smith EF, III, Jugus M, Kinter LB. Effect of thromboxane receptor antagonist, BM 13.505, on the sequelae of endotoxemia in the conscious rat. Eicosanoids 1998; 1(1):27-33.
352. Takano M, Nishimura H, Kimura Y, et al. Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice. J Immunol 1998; 161(6):3019-25.
353. Muntané J, Montero JL, Lozano JM, et al. TNF-α but not IL-1α is correlated with PGE1-dependent protection against acute D-galactosamine-induced liver injury. Can J Gastroenterol 2000; 14(3):175-80.
354. Muntané J, Rodriguez FJ, Segado O, et al. TNF-α dependent production of inducible nitric oxide is involved in PGE1 production against acute liver injury. Gut 2000; 47(4):553-62.
355. Hagmann W, Denzlinger C, Keppler D. Role of peptide leukotrienes and their hepatobilliary elimination in endotoxin action. Circ Shock 1984; 14(4):223-35.
356. Henderson WR. The role of leukotrienes in inflammation. Ann Int Med 1994; 121(9):684-97.
357. Goetzl EJ, Pickett WC. Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. J Exp Med 1981; 153(2):482-7.
358. Shimada K, Navarro J, Goeger DE, et al. Expression and regulation of leukotriene-synthesis enzymes in rat liver cells. Hepatology 1998; 28(5):1275-81.
359. Dieter P, Schulze-Specking A, Decker K. Differential inhibition of prostaglandin and superoxide production by dexamethasone in primary cultures of rat Kupffer cells. Eur J Biochem 1986; 159(3):451-7.
360. Sakaguchi T, Nakamura S, Suzuki S, et al. Participation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats. Hepatology 1999; 30(4):959-67.
361. Anderson BO, Bensard DD, Harken AH. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet 1991; 172(5):415-24.
362. Gardner CR, Laskin JD, Laskin DL. Distinct biochemical responses of hepatic macrophages and endothelial cells to platelet-activating factor during endotoxemia. J Leukoc Biol 1995; 57(2):269-74.
363. Yue TL, Farhat M, Rabinovici R, et al. Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits. J Pharmacol Exp Ther 1990; 254(3):976-81.
364. Tanner A, Keyhani A, Wright R. The influence of endotoxin in vitro on hepatic macrophage lysosomal enzyme release in different models of hepatic injury. Liver 1983; 3(3):151-60.
365. Magilavy DB, Zhan R, Black DD. Modulation of murine hepatic lipase activity by exogenous and endogenous Kupffer-cell activation. Biochem J 1993; 292(Pt 1):249-52.
366. Winwood PJ, Schuppan D, Iredale JP, et al. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells. Hepatology 1995; 22(1):304-15.
367. Peinado-Onsurbe J, Soler C, Galan X, et al. Involvement of catecholamines in the effect of fasting on hepatic endothelial lipase activity in the rat. Endocrinology 1991; 129(5):2599-606.
368. Hironaka K, Sakaida I, Matsumura Y, et al. Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis. Biochem Biophys Res Commun 2000; 267(1):290-5.
369. Arthur MJ. Degradation of matrix proteins in liver fibrosis. Pathol Res Pract 1994; 190(9-10):825-33.
370. Ueno T, Sujaku K, Tamaki S, et al. OK-432 treatment increases matrix metalloproteinase-9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats. Int J Mol Med 1999; 3(5):497-503.